Prosecution Insights
Last updated: October 04, 2026
Application No. 18/703,446

POLYPROPYLENE-BASED RESIN COMPOSITION AND USE THEREOF

Non-Final OA §103
Filed
Apr 22, 2024
Priority
Dec 14, 2021 — JP 2021-202931 +1 more
Examiner
BLEDSOE, JOSHUA CALEB
Art Unit
Tech Center
Assignee
Prime Polymer Co. Ltd.
OA Round
1 (Non-Final)
44%
Grant Probability
Moderate
1-2
OA Rounds
11m
Est. Remaining
97%
With Interview

Examiner Intelligence

Grants 44% of resolved cases
44%
Career Allowance Rate
44 granted / 99 resolved
-15.6% vs TC avg
Strong +53% interview lift
Without
With
+52.7%
Interview Lift
resolved cases with interview
Typical timeline
3y 5m
Avg Prosecution
54 currently pending
Career history
173
Total Applications
across all art units

Statute-Specific Performance

§101
0.8%
-39.2% vs TC avg
§103
62.0%
+22.0% vs TC avg
§102
16.1%
-23.9% vs TC avg
§112
16.4%
-23.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 99 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claims 1-8 are rejected under 35 U.S.C. 103 as being unpatentable over Takashima (JP 2020158554A, hereinafter referring to the attached ESPACENET translation) in view of DOW Chemical (Engage 11547 Polyolefin Elastomer Technical Datasheet). Regarding claim 1, Takashima teaches a polypropylene resin composition that can produce molded articles ([0001]), wherein the inventive composition is defined by: 5 to 47 parts by mass of a propylene polymer (A) having a melt flow rate (230°C, 2.16 kg load) of 50 to 150 g/10 min and a decane-soluble portion of 6% by mass or more ([0011]) 0 to 30 parts by mass of a propylene homopolymer (B) having a melt flow rate (230°C, 2.16 kg load) of 10 to 500 g/10 min ([0011]) 23 to 30 parts by mass of an ethylene-α-olefin copolymer (C) which is a random copolymer of ethylene and α-olefin having 4 to 8 carbon atoms, with a density of 0.850 to 0.890 g/cm3 and a melt flow rate (230°C, 2.16 kg load) of 0.5 to 30 g/10 min ([0011]) 30 to 40 parts by mass of an inorganic filler (D) having an average particle diameter exceeding 8 µm and an aspect ratio exceeding 9.0 ([0011]) Takashima specifically states that the total amount of components (A) through (D) is 100 parts by mass ([0011]). In each case, the ranges above encompass/overlap/are identical to the claimed ranges, establishing prima facie cases of obviousness. Takashima differs from claim 1 because it is silent with regard to the ethylene/α-olefin copolymer having a melting point peak of 110°C or more. In the same field of endeavor, DOW Chemical teaches a particular polyolefin elastomer, ENGAGE 11547, which offers high flow and excellent rubber loading efficiency as a superior impact modifier in thermoplastic polyolefin (TPO) compounds (Dow, p. 1, Overview section). It is prima facie obvious to select a known material based on its art-recognized suitability for its intended use (see MPEP 2144.07). Furthermore, DOW Chemical specifically states that ENGAGE 11547 is suitable for automotive parts (Dow, p. 1, Overview section), Takashima contemplates the formation of both interior and exterior automotive parts (c.f. Takashima [0119]), and Takashima contemplates the importance of the ethylene-α-olefin component in improving the impact strength of the inventive composition (e.g., [0003]). Therefore, it would have been obvious to one having ordinary skill in the art at the time of filing to utilize the ENGAGE 11547 polyolefin elastomer within the composition of Takashima, as taught by DOW Chemical. The instant Specification teaches that ENGAGE 11547 has a peak melting point of 120°C, an MFR at 230°C and 2.16 kg of 9 g/10 min, and a density of 0.866 g/cm3 (c.f. instant Specification at [0135]), which falls within the claimed ranges. Therefore, the composition of Takashima as modified by DOW Chemical meets all of the claimed compositional limitations, in each case establishing prima facie cases of obviousness. Regarding claim 2, Takashima teaches that the propylene polymer (A) is preferably a propylene-based block copolymer obtained from propylene and ethylene. Takashima further indicates that the same has a decane-soluble fraction having an intrinsic viscosity preferably ranging from 2 to 9 dl/g ([0021]), which is identical to the claimed range, establishing a prima facie case of obviousness. Regarding claim 3, Takashima teaches that talc is the preferred filler (D) ([0095]), and that the aspect ratio of the filler is preferably 9.0 or more and 20.0 or less ([0097]), which overlaps the claimed range of “3 or more and less than 15,” establishing a prima facie case of obviousness. Regarding claim 4, Takashima as modified by DOW Chemical is silent with regard to the claimed hot shear test strength characteristic. Nevertheless, Takashima as modified teaches a polypropylene-based composition which is structurally identical to the claimed polypropylene-based composition, which contains all of the same components in all of the claimed amounts. Products of identical chemical compositions cannot have mutually exclusive properties. Where the claimed and prior art products are identical or substantially identical in structure or composition, a prima facie case of obviousness has been established. See MPEP 2112.01. The claimed hot shear test strength characteristic will therefore necessarily be present in Takashima as modified by DOW Chemical, as applied to claim 1, above. Regarding claim 5, Takashima teaches that the inventive composition may be used for automobile exterior members ([0121]). Regarding claim 6, Takashima teaches a molded product of the inventive composition (e.g., [0090] and [0098]). Regarding claim 7, Takashima teaches both injection molding and press molding of the inventive composition ([0120]). Regarding claim 8, Takashima teaches that the inventive composition may be used for automobile exterior members ([0121]). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to JOSHUA CALEB BLEDSOE whose telephone number is (703)756-5376. The examiner can normally be reached Monday-Friday 8:00 a.m. - 5:00 p.m. EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Robert Jones can be reached at 571-270-7733. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JOSHUA CALEB BLEDSOE/Examiner, Art Unit 1762
Read full office action

Prosecution Timeline

Apr 22, 2024
Application Filed
Aug 13, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12742039
METHOD FOR PREPARING GLUTARYL-BRIDGED BIS-BIOGENIC GUANIDINE CHELATE AND METHOD FOR PREPARING POLYBUTYLENE SUCCINATE
2y 6m to grant Granted Sep 22, 2026
Patent 12735571
SILICONE FORMULATION WITH HIGH TEMPERATURE STABILITY AND CLARITY
4y 2m to grant Granted Sep 15, 2026
Patent 12735526
POLYURETHANE-REACTIVE SYSTEM FOR PULTRUSION
3y 8m to grant Granted Sep 15, 2026
Patent 12735522
RESIN COMPOSITION AND ARTICLE MADE THEREFROM
3y 2m to grant Granted Sep 15, 2026
Patent 12729286
CRYSTAL NUCLEATING AGENT COMPOSITION FOR POLYOLEFIN RESIN, AND POLYOLEFIN RESIN COMPOSITION INCLUDING SAID CRYSTAL NUCLEATING AGENT COMPOSITION
4y 0m to grant Granted Sep 08, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
44%
Grant Probability
97%
With Interview (+52.7%)
3y 5m (~11m remaining)
Median Time to Grant
Low
PTA Risk
Based on 99 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month